Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model
- PMID: 17599771
- DOI: 10.1002/art.22721
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model
Abstract
Objective: To explore the relationship between changes in the severity of skin disease and morbidity and mortality in patients with diffuse cutaneous systemic sclerosis (dcSSc).
Methods: From a large single-center cohort, we identified 225 patients with dcSSc for whom serial clinical information was available from within 24 months of the onset of the first non-Raynaud's phenomenon manifestation of SSc. The end points analyzed included death and heart, lung, kidney, and gastrointestinal tract involvement. Latent linear trajectory modeling (LTM) was applied to identify patients with a similar trajectory of modified Rodnan skin thickness score (MRSS) changes over the first 3 years of followup. Clinical outcomes were compared between 3 different LTM subgroups.
Results: LTM permitted classification of 131 patients (58%) into 1 of 3 subgroups with different skin score trajectories. Survival was lowest in the subgroup of patients who had a high baseline skin score and experienced little improvement during followup (P = 0.003). However, the frequency of clinical end points was similar in the subgroup with the most favorable trajectory (i.e., a low initial MRSS and subsequent improvement) and the subgroup with a high baseline MRSS and no improvement. Interestingly, the end point frequency was greatest in the subgroup with a high initial MRSS and subsequent improvement, suggesting that sustained severe skin disease does not necessarily predict the number of visceral complications, and that the relationship between the skin score and internal organ involvement in dcSSc is more complex than previously thought.
Conclusion: Although mortality was highest among patients with the worst skin-related outcomes, no simple relationship between burden of disease and change in skin score was observed.
Similar articles
-
Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.Arthritis Rheum. 2007 Aug;56(8):2740-6. doi: 10.1002/art.22747. Arthritis Rheum. 2007. PMID: 17665460
-
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.Rheumatology (Oxford). 2009 Jan;48(1):70-3. doi: 10.1093/rheumatology/ken408. Rheumatology (Oxford). 2009. PMID: 19056798
-
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.Arthritis Rheum. 2000 Nov;43(11):2445-54. doi: 10.1002/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q. Arthritis Rheum. 2000. PMID: 11083267
-
Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation.J Rheumatol Suppl. 1997 May;48:85-8. J Rheumatol Suppl. 1997. PMID: 9150125 Review.
-
[Contemporaneous clinical picture of systemic sclerosis].Pol Merkur Lekarski. 2010 May;28(167):416-20. Pol Merkur Lekarski. 2010. PMID: 20568410 Review. Polish.
Cited by
-
Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis.Arthritis Res Ther. 2020 Jun 3;22(1):128. doi: 10.1186/s13075-020-02214-y. Arthritis Res Ther. 2020. PMID: 32493508 Free PMC article.
-
Interleukin-1β and Tumor Necrosis Factor-α Gene Polymorphisms in Systemic Sclerosis.Balkan J Med Genet. 2025 Mar 6;27(2):59-68. doi: 10.2478/bjmg-2024-0017. eCollection 2024 Dec. Balkan J Med Genet. 2025. PMID: 40070856 Free PMC article.
-
Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening.Eur Respir Rev. 2011 Dec;20(122):270-6. doi: 10.1183/09059180.00006111. Eur Respir Rev. 2011. PMID: 22130820 Free PMC article. Review.
-
Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance.Curr Rheumatol Rep. 2015 Mar;17(3):21. doi: 10.1007/s11926-014-0484-x. Curr Rheumatol Rep. 2015. PMID: 25777745 Free PMC article. Review.
-
Scleroderma therapy: clinical overview of current trends and future perspective.Rheumatol Int. 2013 Jan;33(1):1-18. doi: 10.1007/s00296-012-2486-1. Epub 2012 Aug 3. Rheumatol Int. 2013. PMID: 23011088 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical